Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

Precision immunotherapy platform in newly diagnosed glioblastoma

July 05, 2026

A phase Ib study is reporting early clinical progress for a personalized immunotherapy approach in newly diagnosed glioblastoma. Researchers evaluated an autologous dendritic cell vaccine pulsed...

On-demand CRISPR control using small-molecule switches

July 05, 2026

Researchers have unveiled two small-molecule-controlled CRISPR systems designed to let clinicians or researchers turn genome editing activity on with a drug and suppress it when the inducer is...

AI modeling to predict response to immune checkpoint inhibitors

July 05, 2026

A new AI model called COMPASS is being positioned as a tool to improve predictions of patient response to immune checkpoint inhibitors. Developed by researchers at Harvard Medical School led by...

Genome-wide clinical informatics: NLP vs ICD-10 capture

July 05, 2026

New research is showing that natural language processing can outperform ICD-10 coding for capturing clinically relevant details from healthcare records. The finding highlights a shift in how...

Noninvasive cardiac tissue monitoring device for organoid pulse measurement

July 05, 2026

An international team including the University of Tokyo has developed a mini “biomechanical well plate” designed to measure the pulse of lab-grown 3D heart tissue (cardiac organoids). The device...

Eye preservation device to enable potential eye transplants

July 05, 2026

Researchers are developing an Eye-in-a-Care-Box (ECaBox) perfusion device that maintains freshly removed eyeballs to reduce degeneration outside the body. The approach aims to preserve the eye’s...

Molecular oncology biology: lysine pyruvylation links metabolism and epigenetics

July 05, 2026

A new study published in Nature Metabolism reports lysine pyruvylation as a previously underappreciated post-translational modification that links glycolysis-derived intermediates to epigenetic...

Next-gen protein therapeutics target: Factor VIII editing concept

July 05, 2026

A post highlights an in-development Human Factor VIII protein candidate associated with Inovio’s pipeline framing for hemophilia. The item references a presentation at the Genomics Biodata...

CRISPR-adjacent biotech enabling: quantum-free switch to improve therapeutic editing?

July 05, 2026

No biotech-sector story in the provided list directly supports this cluster without relying on non-biotech physics content. The remaining items were filtered out as non-biotech or...

Clinical immunobiology: complement receptor C5aR2 signaling mechanisms

July 05, 2026

Researchers have reported mechanistic insights into C5aR2, a complement receptor that appears to deviate from typical signaling behavior within the C5a axis. The work focuses on unique signaling...

CRISPR control with drug-activated switches

July 05, 2026

Researchers led by Wang Yu at the Shenzhen Institutes of Advanced Technology (Chinese Academy of Sciences) reported dual small-molecule-controlled CRISPR genome editing systems—PRINCE and Little...

Personalized dendritic cell vaccine moves in newly diagnosed glioblastoma

July 05, 2026

A phase Ib clinical trial published in Nature Communications reported early efficacy and feasibility signals for a personalized neoantigen-pulsed, autologous dendritic cell vaccine in patients...

AI model boosts prediction of response to immune checkpoint inhibitors

July 05, 2026

Researchers at Harvard Medical School unveiled COMPASS, an AI model designed to predict patient response to immune checkpoint inhibitors (ICIs). Reported as outperforming existing approaches,...

Next-generation ADC concept: antibody-peptide fusions

July 05, 2026

ATB Therapeutics presented “atbodies,” antibody-peptide fusions designed to address ADC off-target toxicity and widen the therapeutic window. Speaking at the Antibody Engineering and Therapeutics...

Vision preservation tech targets eye transplant feasibility

July 05, 2026

Researchers described an “Eye-in-a-Care-Box” device (ECaBox) intended to maintain and revive freshly removed eyes through perfusion, supporting the case for future eye transplant viability. The...

Immune pathway research: clarifying C5aR2 signaling biology

July 05, 2026

Researchers reported new molecular insights into C5aR2, a complement receptor described as having atypical signaling behavior compared with classical complement pathways. The work outlines how...

Metabolism-to-epigenetics bridge via lysine pyruvylation

July 05, 2026

A study published in Nature Metabolism reported lysine pyruvylation (Kpy), a newly described post-translational modification that links glycolysis intermediates to epigenetic regulation. The...

Pilot therapeutic device for Parkinson’s

July 05, 2026

A randomized, double-blind, placebo-controlled pilot trial published in npj Parkinson’s Disease reported evidence supporting a sternum-worn vibrotactile device as a non-pharmacological adjunct for...

Biotech AI’s clinical adoption risks – skills and performance dropoffs

July 05, 2026

A report on AI-assisted clinical workflows highlighted evidence that physician performance can drop when decision-support tools are unavailable. It cites a survey indicating high concern among...

Bioengineering platform: microgrid-analog optimization not included

July 05, 2026

No eligible biotech/healthcare stories were provided in this slot after filtering out non-biotech items, including computing, energy systems, environmental cleaning, and unrelated submissions. The...